Clinical trials in the gene therapy of arthritis

Clinical Orthopaedics and Related Research

Volumn 379, Issue SUPPL., 2000, Pages

  Evans, C H ^a   Ghivizzani, S C ^a   Herndon, J H ^a   Wasko, M C ^a   Reinecke, J ^a   Wehling, P ^a   Robbins, P D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; THYMIDINE KINASE;

ARTHRITIS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA MODIFICATION; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN TISSUE; JOINT PROSTHESIS; METACARPOPHALANGEAL JOINT; NONHUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; POSTMENOPAUSE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SYNOVECTOMY;

EID: 0033770975     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-200010001-00039     Document Type: Conference Paper

References (24)

1. Interleukin-1 receptor antagonist: Role in biology
2. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin- 1 receptor antagonist protein in the knee
3. Intraarticular expression of biologically active interleukin- 1 receptor antagonist protein by ex vivo gene transfer
4. Gene transfer to synoviocytes: Prospects for gene treatment for arthritis
5. Prolonged systemic expression of human IL-1 receptor antagonist protein in sera of lethally irradiated mice reconstituted with hematopoietic stem cells transduced with a retrovirus containing the IL- 1ra gene
6. Treatment of rheumatoid arthritis with recombinant human interleukin- 1 receptor antagonist
7. Dose-range and dose-frequency study of recombinant human interleukin- 1 receptor antagonist in patients with rheumatoid arthritis
8. Gene therapy for rheumatic diseases
9. Lessons learned from gene transfer approaches
10. Blocking cytokines with genes
11. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis
12. Direct adenoviral-mediated gene transfer of IL-1 and TNF-α soluble receptors to rabbit knees with experimental arthritis has local and distal antiarthritic effects
13. Feasibility of adenovirus-mediated nonsurgical synovectomy in collagen-induced arthritis-affected rhesus monkeys
14. Pharmacokinetics, safety, and immunomodulatory effects of human recombinant interleukin- 1 receptor antagonist in healthy humans
15. Suppression of experimental arthritis by gene transfer of interleukin- 1 receptor antagonist cDNA
16. Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model
17. Human IL- 1Ra gene transfer into human synovial fibroblasts is chondroprotective
18. Direct gene delivery to synovium: An evaluation of potential vectors in vitro and in vivo
19. Suppression of antigen-induced arthritis by gene therapy
20. Adenoviral-mediated gene transfer to rabbit synovium in vivo
21. Molecular lysis of synovial lining cells by in vivo herpes simplex virus-thymidine kinase gene transfer
22. Influence of IL- 1 receptor blockade on the human response to endotoxemia